Contraction-released heme iron may sustain lipid damage and delay muscle recovery
In some aging humans with postinfectious exertional intolerance, contraction-released heme iron could sustain new lipid damage despite early reconditioning. Sensitive tests finding no preceding catalytic rise or no less injury after selective interruption would constrain this mechanism in the tested compartment and window.
Omega Point 1.5
Stage of verification
- Hypothesis published2026-10-10
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Metabolite or ion
Heme-associated iron
An iron pool associated with heme that can be catalytically available
Where this hypothesis actsAfter contraction in aging humans with postinfectious exertional intolerance; compartment unidentified
Hypotheses on this target 1
Supplementation
Accelerated excretion
Composition restoration
What is proposed
Suppress the catalytic activity of the implicated heme-associated iron pool
With whatNot stated in the record
HowConditional sequestration with confirmed compartment-level target engagement; no selective method is supplied. Assess direct effects on contraction, metabolism and host defense
Possible result
Possible reduction in subsequent oxidative injury, delayed force loss and incomplete recovery
From the recordan ordinary contraction could release a localized, catalytically available heme-associated iron pool that initiates lipid radical propagation

Metabolism and energy
Lipid peroxidation
A process involving peroxide-chain propagation that can cause persistent cellular injury
Where this hypothesis actsFollowing an initiating contraction in postinfectious exertional intolerance; compartment unidentified
Hypotheses on this target 7
Inhibition4
Activation
Function preservation
Supplementation
Feedback restoration
Direct measurement
What is proposed
Interrupt continuing lipid radical propagation after the initiating contraction
HowConditional, independently acting chain termination with target engagement and off-target controls; no selective chain-termination method is supplied
Possible result
Possible reduction in newly forming damage and subsequent force loss while retaining useful adaptation and defense
From the recordConvergent sequestration and independently acting chain termination support attribution only after target engagement and direct off-target routes are examined, not simply because both rescue.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Muscle strength might return during rehabilitation while the conditions for another loss remain. The unexpected move is to borrow from the chemistry of corrosion: ordinary muscle activity could release an iron-containing substance that keeps damaging muscle after the activity ends. This is a proposal generated by the pipeline, not a measured result, and its suggested relevance is to some older people who tolerate exertion poorly after an infection.
- Ordinary muscle contraction is proposed to release a local, chemically available heme-associated iron pool.
- The released catalyst is proposed to start damaging reactions in nearby fats.
- A brief initiating event is proposed to become continuing formation of new damage after contraction ends, rather than leave only old damage products behind.
- Continuing chemical damage is proposed to injure muscle despite genuine early improvement in capacity.
- That injury is proposed to cause delayed strength loss and incomplete recovery; interrupting the chemistry would help only if it materially contributes to those outcomes.
A spark can go out while a fire keeps consuming fresh material. Ash left behind is different from a fire that is still burning.
Where the picture breaks: The proposed muscle chemistry is not combustion. Continuing damage might still require repeated outside triggers, and the supplied material does not establish that the reaction can sustain itself after those triggers stop.
- Master questionstep 01 of 04
Human aging is the target of a search for ways to slow it radically.
Rests on: The supplied goal sets radical slowing of human aging as the desired outcome; it does not specify a mechanism.
Stated in the chain - Goal pillarstep 02 of 04
Age-related losses are proposed to accumulate when another recovery cycle begins before the previous one finishes.
Rests on: The aging goal supplies the outcome of interest, but does not establish overlapping, incomplete recovery as a cause.
AssumptionThe chain takes accumulation through unfinished recovery cycles as a candidate explanation of aging; the supplied material does not establish that general relationship.
- Gap questionstep 03 of 04
Rehabilitation might restore measured reserve, the capacity available to meet physical demands, yet accelerate later functional loss in older people with poor exertion tolerance after infection. That outcome would challenge the prediction that reversing deconditioning, the loss of capacity associated with reduced activity, completes recovery.
Rests on: The preceding stage supplies the distinction between apparent improvement and unfinished recovery. It does not supply the choice of population or the prediction that reversing reduced-activity losses should complete recovery.
AssumptionThe chain assumes this population and rehabilitation contrast provide a useful setting for examining unfinished recovery. It does not establish that rehabilitation actually accelerates subsequent loss.
- Hypothesisstep 04 of 04
Ordinary contraction could release a local heme-associated iron catalyst, a substance that promotes chemical reactions, despite genuine early gains in capacity. It could initiate lipid radical propagation, a chain reaction in which reactive molecules pass damage between fats, and continuing damage could delay recovery and reduce strength later.S8
Rests on: The preceding question supplies the puzzle of restored capacity followed by later loss. The corrosion analogy supplies a proposed explanation, while S8 supplies a narrower chemical basis: its 2023 Antioxidants review describes heme-associated iron promoting oxidation, chemical reactions that can damage cell fats, after heme enters a cell membrane. It does not establish release during contraction, continuing damage afterward, or functional loss in the proposed human population.
Supported by literature
What is carried, and what is not. Of the five proposed mechanism links listed here, screened literature directly supports part of one: S8 describes heme-associated iron promoting fat oxidation in its 2023 Antioxidants review, but does not establish the muscle-activity trigger or later human functional loss. S9, a 2020 Frontiers in Oncology review, describes related reactions involving iron released from heme, and S10, a 2022 Frontiers in Molecular Biosciences review, reports iron accumulation and fat damage after exhaustive exercise in mice; neither establishes the proposed iron pool, the ordinary-activity setting, or the complete sequence in older humans.S8S9S10
Where the reasoning is carried by something unstated · 2
- Goal pillar. The chain takes accumulation through unfinished recovery cycles as a candidate explanation of aging; the supplied material does not establish that general relationship.
- Gap question. The chain assumes this population and rehabilitation contrast provide a useful setting for examining unfinished recovery. It does not establish that rehabilitation actually accelerates subsequent loss.
How a result here could mislead · 3
- Sample collection could release iron or create fat damage, making laboratory handling look like a contraction-triggered event inside muscle. Measuring total iron could also mistake an unrelated iron pool for the proposed catalyst. What closes it: Samples require rapid stabilization, handling blanks that reveal contamination or handling effects, and independent identification of the chemical forms present. The work must distinguish heme still held in protein, released heme-associated catalyst, and iron subsequently separated from heme, while preserving their original location and chemical state. The supplied material does not establish that this preservation is feasible.
- Damage products remaining after contraction could be mistaken for continuing damage formation. Even newly forming damage could reflect repeated triggers from infection, inflammation, disrupted muscle structures, or other ongoing injury rather than a self-sustaining chemical process. What closes it: New damage formation and removal of existing products must be measured separately. A defined period after contraction and an explicit model of reaction rates must bound continuing triggers, including chemical recycling within the proposed process. No duration or numerical bound is supplied. Without that separation, the evidence could support chemistry that amplifies continuing injury, but could not identify an autonomous process.
- An intervention could preserve strength by reducing muscle work or directly changing energy use, infection, or immune defense, and that protection could be credited to the proposed catalyst. Conversely, failure to protect could be mistaken for failure of the hypothesis when the intervention never reached or altered its target. What closes it: The intended catalyst must be shown to change in the relevant location, followed by reduced new oxidation before later injury and strength outcomes. Comparisons require documented activity, imposed demand, living tissue amount, strength, injury and infection before intervention, with comparable subsequent imposed demand where feasible and controls for direct alternative actions. Later improvements caused by chemical protection must remain part of the measured benefit. No selective intervention method is supplied, and lower damage-product levels alone would not establish functional protection.
What would make this wrong. The specified mechanism would be undermined by sufficiently sensitive measurements, with the relevant chemical state preserved, showing that the proposed available heme-associated catalyst does not rise before new fat damage, or that no continuing new damage occurs in the specified location and period. Its claimed contribution to functional loss would be undermined if selective, verified interruption reduced that new damage without reducing subsequent injury, strength loss or recovery delay under comparable imposed demands. Dependence on continuing outside triggers would reject the autonomous version while leaving an injury-amplifying role possible. Such negative results would constrain the tested location and period, not establish a rival explanation.
What it would change. If the proposal held, restored strength alone would not establish completed recovery in the affected population: ongoing chemical injury could contribute to the next loss. Efforts to prevent accumulating loss would therefore need to distinguish rebuilt capacity from termination of damaging chemistry. That would not establish that interrupting this process radically slows human aging, that it applies beyond the identified population and tissue, or that it excludes defective replacement proteins, mechanically linked failures, or renewed pathogen production as upstream causes.
Sources read · 7
Induction of heme oxygenase-1 (HSP32) mRNA in skeletal muscle following contractions. · The American journal of physiology · 1997
“Increases in HSP32 mRNA may underlie an inducible antioxidant pathway in muscle responsive to metabolic stresses associated with repeated muscle contractions.”
Does not settle: The source does not establish contraction-induced release of catalytically available heme-associated iron, its species, accessibility or compartment; lipid radical initiation or continued propagation; delayed functional loss or incomplete recovery; effects in aging humans with postinfectious exertional intolerance; or whether interrupting this chemistry improves SPV_4 or SPV_5.
“This hypothesis posits that chronically elevated endogenous production of carbon monoxide (CO), primarily through the enzyme heme oxygenase-1 (HO-1), is a previously underappreciated cause of these syndromes.”
Does not settle: The abstract does not establish contraction-released heme-associated iron, its chemical species, accessibility or compartment; lipid-radical initiation or propagation; delayed muscle damage or recovery; effects in aging humans with postinfectious exertional intolerance; or whether safely interrupting this proposed chemistry improves SPV_4 or SPV_5.
“This hypothesis posits that chronically elevated endogenous production of carbon monoxide (CO), primarily through the enzyme heme oxygenase-1 (HO-1), is a previously underappreciated cause of these syndromes.”
Does not settle: The abstract does not establish contraction-released heme-associated iron, its species, accessibility or compartment; lipid-radical initiation or continued propagation; delayed muscle damage or recovery; effects in aging humans with postinfectious exertional intolerance; or whether interrupting such chemistry improves SPV_4 or SPV_5.
“This hypothesis posits that chronically elevated endogenous production of carbon monoxide (CO), primarily through the enzyme heme oxygenase-1 (HO-1), is a previously underappreciated cause of these syndromes.”
Does not settle: The abstract does not establish contraction-released heme-associated iron, its species, accessibility or compartment; lipid-radical initiation or continued chain propagation; delayed muscle damage or recovery in aging humans; or whether interrupting that chemistry improves SPV_4 or SPV_5.
Heme: The Lord of the Iron Ring · Antioxidants · 2023
“Once heme has intercalated into the membrane, the iron in it can catalyze the oxidation of cell membrane lipids, leading to the formation of lipid peroxides.”
Does not settle: The source does not establish contraction-triggered heme release, a localized catalytically available pool in skeletal muscle, radical-chain propagation after contraction, delayed functional loss or incomplete recovery, effects in aging humans with postinfectious exertional intolerance, or improvement in SPV_4 and SPV_5 after a safe intervention.
The Multifaceted Role of Heme in Cancer · Frontiers in Oncology · 2020
“LOOH is then broken down by the iron released by heme to produce free radicals and, subsequently, aldehyde molecules like malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) ( ).”
Does not settle: The source does not establish contraction-triggered heme release in skeletal muscle, a localized catalytically available heme-associated iron pool in aging humans with postinfectious exertional intolerance, continuing post-contraction radical propagation, delayed functional loss, incomplete recovery, or effects on SPV_4 and SPV_5.
Ferroptosis and its role in skeletal muscle diseases · Frontiers in Molecular Biosciences · 2022
“The experimental data showed that there were characteristics related to ferroptosis in skeletal muscle of EEIF mice, such as accumulation of iron, lipid peroxide, decreased expression of GPX4 and GSH, suggesting that ferroptosis may participate in the process of EEIF disease ( ).”
Does not settle: The source does not establish an ordinary-contraction-triggered, localized catalytically available heme-associated iron pool; continuing radical-chain propagation after contraction; delayed functional loss or incomplete recovery; or effects in aging humans with postinfectious exertional intolerance. The cited exercise evidence concerns exhaustive exercise in mice and does not identify the iron species, accessibility, compartment, timescale, causal ordering, or effects on SPV_4 and SPV_5.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Does rehabilitation restore capacity yet accelerate later decline in older people whose symptoms worsen with exertion after infection?
Original wording · exactly as the pipeline generated it
Does rehabilitation that restores measured reserve nevertheless accelerate subsequent functional loss in aging humans with postinfectious exertional intolerance, contradicting the prediction that reversing deconditioning closes the recovery cycle?
What this question is asking
The question concerns whether improving a person's measured physical capacity can coexist with faster subsequent loss of everyday abilities. It asks about rehabilitation in aging humans with postinfectious exertional intolerance, meaning difficulty tolerating activity after an infection, including worsening symptoms following effort. The proposed sequence is that rehabilitation first restores measured reserve, or capacity available beyond ordinary demands, but returning to ordinary activity then produces progressively longer recovery, greater effort for the same tasks, or lasting loss of capacity. Establishing acceleration would require a comparison showing that later function declines faster because of rehabilitation, rather than simply showing that some symptoms remain. The question assumes that reversing deconditioning should otherwise close the recovery cycle, meaning that repeated activity and recovery stop leaving accumulating losses.
- Rehabilitation
- Care intended to improve or recover functioning. It includes different combinations of treatments, so findings about one programme do not automatically describe all rehabilitation.
- Measured reserve
- Capacity available beyond what ordinary activities require. The question treats this as something rehabilitation can restore, but the supplied material does not provide a shared measurement or a criterion for full restoration.
- Exercise capacity and exercise tolerance
- How much physical effort a person can perform or sustain under specified conditions. These measurements can improve without establishing how reliably everyday activities can be repeated and recovered from.
- Postinfectious exertional intolerance
- Difficulty tolerating physical or mental effort after an infection, potentially including symptoms that worsen following activity. It describes a pattern of limitations rather than a single established cause.
- Aging humans
- The population named by the question, rendered as older people in the short question. The input specifies no age range and does not establish an aging-specific result.
- Deconditioning
- Loss of physical capacity associated with reduced activity. The question tests whether reversing this loss is enough to prevent repeated activity from producing accumulating limitations.
- Recovery cycle
- The question's model of activity followed by recovery. Closing the cycle means that successive ordinary activities stop producing progressively longer recovery, greater effort, or lasting capacity loss; it is not a validated measurement supplied by these sources.
- Functional decline
- Loss of ability to perform activities over time. Accelerated decline means a faster rate of loss relative to a relevant comparison, not simply a worse result on one occasion.
- Persistent injury
- Lasting damage, which the pipeline proposes might coexist with improved capacity. Symptoms or reduced performance alone do not establish such damage in the supplied evidence.
- Peak oxygen consumption and aerobic capacity
- Peak oxygen consumption is the highest rate of oxygen use measured during an exercise test. Aerobic capacity describes the capacity to sustain activity using oxygen-dependent energy production; both concern exercise performance rather than directly measuring lasting recovery.
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- A named illness involving substantial limitations and worsening symptoms after exertion. Its presence in several sources does not establish that their participants match the question's aging, postinfection population.
- Post-exertional malaise
- Worsening of symptoms following physical or mental effort. It concerns the response after activity, which may differ from the capacity measured during the activity itself.
- Blood lactate
- Lactate is a substance involved in how the body processes and transfers energy, and its concentration can be measured in blood during exercise. S6 reports changes in this measurement; those changes do not themselves establish persistent injury.
- Maximal exercise test
- A test intended to assess exercise performance near a person's maximum effort. Repeating such tests can reveal short-term changes after exertion, but does not by itself measure the consequences of repeated ordinary activity over longer periods.
- Graded exercise therapy
- An exercise-based treatment involving planned increases in activity over time. It is a particular treatment approach discussed by S4 and S10, rather than a synonym for every form of rehabilitation.
- Cross-sectional design and survey association
- A cross-sectional study examines participants without following the full sequence of changes required by this question. A survey association means reported experiences occur together; it does not by itself establish which event caused another.
Rehabilitation restores measured reserve, and reversing deconditioning is sufficient to close the recovery cycle so that ordinary activity does not progressively increase recovery time, relative effort, or residual reserve loss.
Rehabilitation is care intended to improve functioning, and deconditioning is a reduction in physical capacity associated with inactivity. The assumption is that rebuilding this capacity leaves enough capacity beyond everyday demands for repeated activity to stop producing accumulating losses. If that assumption held, restored capacity would be evidence that the process causing repeated loss had ended.
S2 reports improved maximal exercise tolerance, and S8 reports improvements in several measures of physical capacity and symptoms. These establish a narrower claim: selected outcomes can improve during rehabilitation. Neither establishes full restoration of reserve or shows that those improvements prevent progressively worse recovery after ordinary activity. S1 reports incomplete recovery despite improved breathlessness and walking distance. The supplied sources therefore support improvement in selected outcomes, but do not establish the proposed sufficiency of reversing deconditioning.S1S2S8
The same question asked without the part nothing read establishes:
- In aging humans with symptoms that worsen after exertion following infection, does rehabilitation that improves measured physical capacity accelerate later loss of everyday function?
- In this population, do improvements in measured physical capacity persist alongside stable recovery time and effort across repeated ordinary activities?
- Capacity improves, but later decline accelerates If rehabilitation first restores measured capacity and causes a faster subsequent loss of everyday function, that restoration is insufficient to end the accumulating loss described by the question. Better exercise results could then coexist with worsening ability to sustain ordinary activity. This outcome alone would not identify the cause of the later loss or establish persistent injury.
- Capacity improves and recovery remains stable If ordinary activity subsequently requires no progressively greater effort or recovery time and leaves no accumulating capacity loss, the observed pattern would fit the predicted recovery cycle. It would support lasting benefit over the period observed, although it would not by itself establish that reversing deconditioning was the sole cause.
- Capacity improves, but limitations persist without faster decline Some exercise measures could improve while symptoms or everyday limitations remain. That would show incomplete recovery, but would establish neither rehabilitation-caused acceleration of decline nor the predicted end of accumulating losses.
The proposed explanation starts with inactivity reducing physical capacity, which makes ordinary tasks consume a larger share of the capacity remaining. Rehabilitation would increase capacity, and the explanation predicts that ordinary tasks would consequently become easier to sustain and recover from. If restored capacity instead accompanies progressively worse recovery and faster loss of everyday function, an improved exercise result would not establish lasting recovery. Conversely, worsening after an exercise test or reported harm during rehabilitation does not by itself establish that rehabilitation first restored capacity and then caused faster decline. Confusing these sequences could misclassify either a temporary improvement as durable recovery or a short-term setback as evidence of accelerated long-term loss.
RL-3 rehabilitation improves selected function; RL-2 intolerance findings challenge whether greater restored activity reliably ends the underlying loss process.
Return to ordinary activity must not progressively increase recovery time, relative effort or residual reserve loss across subsequent natural episodes.
The promising rehabilitation mechanism fails as a sufficient explanation if restored measured reserve coexists with greater persistent injury and later functional loss.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
SCOUT from corrosion chemistry and radical-chain kinetics, unverified: In a subset of aging humans with postinfectious exertional intolerance, an ordinary contraction could release a localized, catalytically available heme-associated iron pool that initiates lipid radical propagation despite genuine early reconditioning. Continued formation of oxidative damage after the initiating contraction could then cause delayed functional loss and incomplete recovery. The heme-derived species, accessibility and compartment are part of the hypothesis: total iron, ferritin stores or labile nonheme iron cannot substitute for that pool. The radical state remains an active catalyst with susceptible material and continuing propagation, not merely persistent end products or generic oxidative stress. It could be an autonomous post-initiation process or a downstream amplifier of mechanical, inflammatory or infectious injury; those versions require separation. A safe activity-preserving interruption could improve SPV_4 and SPV_5 only if the chemical injury materially drives them; neither effect nor their ordering is established.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Under shared_conditions and the time-indexed effect definition in competition_interpretation, identify an endogenous physiological species and compartment: distinguish heme retained in protein, released heme-associated catalyst and any subsequent conversion to dissociated nonheme iron. No one readout substitutes for another; source, accessibility, concentration, conversion kinetics and contraction threshold remain unknown. Conditional on their identification and artifact-controlled preservation, the implicated catalytic rise must precede newly forming lipid oxidation and injury. Quantify formation separately from clearance and follow new oxidative flux after contraction and before delayed force loss. Measure or bound fresh initiation from inflammation, mitochondrial dysfunction, ischemia/reperfusion, mechanical disruption and peroxide breakdown, together with propagation and termination in the relevant compartment. Operationally, the stronger autonomous version predicts continuing consequential new damage over a specified post-initiation window after the initiating contraction ends and continuing external initiation is absent or bounded too small to explain the flux under an explicit kinetic model. Internal catalyst/substrate/peroxide cycling must be specified within that model rather than silently counted as zero initiation. No duration or quantitative bound is supplied. If ongoing initiation cannot be bounded or independently varied, autonomy is unidentified; an input-dependent chemical amplifier remains possible. The ordinary alternative predicts continued insults or slowly cleared products without the proposed preceding catalytic transition. For a future delayed interruption define t0 after the documented initiating history and before intervention. Compare pre-t0 actual work and imposed demand, viable mass, force, injury, catalyst state and productive pathogen burden, then estimate the total subsequent protection from target-engaged interruption against its control under a comparable independently imposed demand schedule where feasible. Measure compartment-level target engagement and new oxidation before subsequent injury and force change. Direct tool actions on metabolism, contraction, host defense or pathogen growth that bypass the intended catalytic change are alternative intervention pathways requiring specific controls if feasible; if unresolved, rescue alone cannot attribute protection to the proposed catalyst. Changes after t0 in viability, injury, force, achieved work, inflammation or pathogen burden caused by chemical protection or feedback belong to the total effect and must not be matched away. Do not require subsequent viability or injury equality to test preservation. A changed imposed load or direct contractile impairment is reported separately as an exposure tradeoff. A contrast holding specified later infection or injury trajectories fixed concerns a narrower controlled direct effect and is attempted only when independently feasible with overlap; it is not a prerequisite for the total amplifier effect. Convergent sequestration and independently acting chain termination support attribution only after target engagement and direct off-target routes are examined, not simply because both rescue. Conditional restoration must reproduce the identified physiological species, localization, concentration and timing; bulk toxic iron addition is not a validating reversal. Relate the amount and duration of new oxidation to subsequent force loss and the fraction of recovery delay/residual loss, with useful adaptation and defense assessed. Lower products without less injury or functional loss are insufficient. Iron dependence can identify a downstream amplifier without autonomy or exclusion of mechanical/infectious causes. Adequate sensitive negative tests constrain the specified compartment/window only and do not establish a rival.
States a measurable outcome; comparing rivals needs more conditions. The chunk predicts a conditional temporal ordering and continued new damage under stated conditions. These are measurable outcomes despite the missing duration and quantitative bound. Autonomy remains unidentified if ongoing initiation cannot be bounded or independently varied. No rival prediction was supplied. The chunk provides an explicit rejection condition: lower products alone are insufficient without reduced injury or functional loss. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Begin with rapid stabilization, handling blanks and independent speciation confirmation in ethically obtained samples; collection can release iron or cause oxidation. Participant-derived preparations must retain the endogenous species and biochemical state. Time-resolved chemistry must assess formation and clearance as well as tissue force/viability and inflammatory/mechanical injury. No selective sequestration, chain-termination or physiological restoration method is supplied. Assess relevant-compartment target engagement, pre-intervention actual work and demand, and direct off-target metabolism, host defense, pathogen growth and contraction before attributing rescue. Follow later work, viability, force, infection and adaptation as potential effects or mediators; changes attributable to chemical protection are retained in the total effect. No available means of separating those pathways or of bounding initiation is assumed. If species cannot be preserved or selectively altered, evidence remains observational. These are conditional research tests, not human chelation or antioxidant regimens.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Under shared_conditions and the time-indexed effect definition in competition_interpretation, identify an endogenous physiological species and compartment: distinguish heme retained in protein, released heme-associated catalyst and any subsequent conversion to dissociated nonheme iron. No one readout substitutes for another; source, accessibility, concentration, conversion kinetics and contraction threshold remain unknown. Conditional on their identification and artifact-controlled preservation, the implicated catalytic rise must precede newly forming lipid oxidation and injury. Quantify formation separately from clearance and follow new oxidative flux after contraction and before delayed force loss. Measure or bound fresh initiation from inflammation, mitochondrial dysfunction, ischemia/reperfusion, mechanical disruption and peroxide breakdown, together with propagation and termination in the relevant compartment. Operationally, the stronger autonomous version predicts continuing consequential new damage over a specified post-initiation window after the initiating contraction ends and continuing external initiation is absent or bounded too small to explain the flux under an explicit kinetic model. Internal catalyst/substrate/peroxide cycling must be specified within that model rather than silently counted as zero initiation. No duration or quantitative bound is supplied. If ongoing initiation cannot be bounded or independently varied, autonomy is unidentified; an input-dependent chemical amplifier remains possible. The ordinary alternative predicts continued insults or slowly cleared products without the proposed preceding catalytic transition. For a future delayed interruption define t0 after the documented initiating history and before intervention. Compare pre-t0 actual work and imposed demand, viable mass, force, injury, catalyst state and productive pathogen burden, then estimate the total subsequent protection from target-engaged interruption against its control under a comparable independently imposed demand schedule where feasible. Measure compartment-level target engagement and new oxidation before subsequent injury and force change. Direct tool actions on metabolism, contraction, host defense or pathogen growth that bypass the intended catalytic change are alternative intervention pathways requiring specific controls if feasible; if unresolved, rescue alone cannot attribute protection to the proposed catalyst. Changes after t0 in viability, injury, force, achieved work, inflammation or pathogen burden caused by chemical protection or feedback belong to the total effect and must not be matched away. Do not require subsequent viability or injury equality to test preservation. A changed imposed load or direct contractile impairment is reported separately as an exposure tradeoff. A contrast holding specified later infection or injury trajectories fixed concerns a narrower controlled direct effect and is attempted only when independently feasible with overlap; it is not a prerequisite for the total amplifier effect. Convergent sequestration and independently acting chain termination support attribution only after target engagement and direct off-target routes are examined, not simply because both rescue. Conditional restoration must reproduce the identified physiological species, localization, concentration and timing; bulk toxic iron addition is not a validating reversal. Relate the amount and duration of new oxidation to subsequent force loss and the fraction of recovery delay/residual loss, with useful adaptation and defense assessed. Lower products without less injury or functional loss are insufficient. Iron dependence can identify a downstream amplifier without autonomy or exclusion of mechanical/infectious causes. Adequate sensitive negative tests constrain the specified compartment/window only and do not establish a rival.
- Rival 01 of 03Sequence errors in new muscle proteins may shorten their working life and cause later force loss
Not yet published.
What would separate themSequence errors in new muscle proteins may shorten their working life and cause later force loss predicts: Under shared_conditions and the time-indexed effect definition in competition_interpretation, excess independently confirmed amino-acid sequence errors in dated new contractile material must precede loss of function or removal of those same incorporated proteins and delayed force decline. Quantify absolute erroneous and correct abundance by protein and sequence site, defective fraction, intact incorporation, initial mechanical contribution and subsequent functional and physical survival. The conditional burden-to-force assumption is that the affected sites and amount, together with their contribution and loss, can account for a material part of muscle-level residual loss beyond baseline pathology; no universal error-frequency threshold or linear mapping is assumed. Detection of a rare error alone does not establish consequential burden, and rarity alone does not exclude it: affected sites, intact mechanical contribution and subsequent functional loss must determine relevance. First establish a feasible way to link the same error-bearing intact structures to initial mechanics and later fate; whole-muscle early gain alone does not do this. Distinguish force failure before removal from removal of still-competent material, protective quality control, dilution, heterogeneous fiber loss and replacement, and measure the removal-to-functional-replacement balance. If this structure-level linkage cannot be established, retain that causal step as unverified. Stable-isotope labeling dates synthesis; it does not identify mistranslation or distinguish degradation from dilution. The ordinary alternative at the same initial states, imposed tolerated demands and times is abnormal folding, assembly, oxidation or removal of correct-sequence proteins during incomplete recovery without antecedent mechanically consequential sequence-error excess. Only if a state-preserving preparation and a sufficiently selective correction become feasible, define t0 before correction and compare the total subsequent effect of lower verified error production with the control trajectory. Record pre-t0 total synthesis, protein composition, folding/assembly, degradation, energetics, actual work history, viable mass, existing injury and competing causes, and use a comparable independently imposed demand schedule where feasible. Verify error reduction before its proposed consequences. Assess direct tool effects on synthesis amount/composition, assembly, degradation, metabolism, force or viability that bypass error reduction; if they cannot be separated, any rescue identifies only a total intervention effect, not a fidelity-specific effect. In contrast, changes after t0 in assembly/folding, removal, energetics, achieved work, viable mass or force caused by fewer errors are legitimate mediators or outcomes of the total fidelity effect and must not be matched away. Measure their trajectories and distinguish them by time order and, only if feasible, orthogonal controls or staged interventions. A controlled direct-effect comparison fixing a specified mediator history is an additional question only if independently manipulable with adequate overlap and without introducing new injury; inability to fix it does not refute the total mechanism. Reduced imposed demand or direct suppression of contraction is separately reported, not presented as exposure-preserving fidelity rescue. Existing erroneous material may need replacement, so immediate full recovery is not required. Normal fidelity at sufficient site/protein coverage, sensitivity and timing, with bounds excluding a burden capable of the observed loss, weakens this mechanism locally. Rescue through lower strain, downstream chemistry or pathogen suppression can preserve defective material or remove an upstream driver, and does not refute a fidelity contribution or establish a different pure model.
- Rival 02 of 03What would separate them
Damaged connective-tissue paths may spread failure between otherwise capable muscle regions predicts: Under shared_conditions and the time-indexed effect definition in competition_interpretation, map repeatable regional force contributions, capacities and a named vulnerable physical load-bearing path before a focal event. Define t0 immediately before that event, separately from any earlier coupling intervention. Record pre-event strain histories and rates, fatigue cycles, recovery intervals, stress concentrations, perfusion, recruitment and achieved work, and contemporaneous externally imposed common demand that is not generated by the event. Compare linked and unlinked regions with overlap in those pre-event states and common inputs. The focal prediction is a localized path event followed by demonstrable mechanically transmitted change and persistent injury/force loss in otherwise capable linked regions. Temporal/spatial resolution must separate path transmission from an independently traveling perfusion or recruitment disturbance. An ordered lesion map alone does not establish that separation. The ordinary alternative permits correlated loss through common overload, incomplete recovery, marginal weakness or shared perfusion/activation without a path-transmitted event. Equal total work and peak strain alone do not control that alternative. The primary target is the total effect of the demonstrated path event or, separately, of a feasible coupling modification on later joint injury and task retention. Event-generated redistribution of strain, stress concentration, perfusion or recruitment, and resulting changes in marginal failure probabilities, are possible transmission mediators; they are measured after t0, not conditioned away. No excess beyond all post-event local histories or post-event marginals is required for this total effect. Identification still requires adequate control of pre-event common causes and independent evidence of the named transmitted process; unexplained correlation is insufficient. A future noninjurious modification must first be validated in an architecture-preserving preparation, with sham handling and comparable pre-intervention state and independently imposed demand where feasible. Measure its direct effects on capacity, force transmission and viability, its effect on the path event/transmission, subsequent local doses, achieved task force and displaced injury. Protection caused by lower imposed demand, or redistribution with no demonstrated path-event sequence, is a meaningful total intervention result but does not alone identify this damaged-path mechanism. Changes in local dose generated by a demonstrated path effect remain part of that effect even without post-event exposure overlap. A controlled direct architecture effect at fixed local histories is a distinct, optional contrast requiring feasible independent control and overlap; absence of either leaves that narrower contrast unidentified rather than disproving total path-mediated injury. Useful force retention, independence and absence of displaced harm are separately required for an activity-preserving benefit. Distinguish persistent structural/functional injury from transient inhibition. Lack of reproducible regions or the required vulnerable path weakens this particular import; a good aggregate fit, unexplained cofailure or a rival rescue alone cannot identify or exclude it. Biochemical and infectious processes may lie upstream or downstream. For the conservative benefit scenario in process_hypothesis, assess later regional loading, task force, independence, viability and injury elsewhere as outcomes at the declared ordinary tasks across repeated episodes. A loading increase alone does not negate a demonstrated total path effect; any broader activity-preserving benefit requires a prospectively specified clinically meaningful net comparison of retained function and injury, with the individual outcomes reported separately. No acceptable numerical tradeoff or safe manipulation is supplied.
- Rival 03 of 03What would separate them
Rebuilding after exertion may enable a tissue pathogen reservoir to produce new pathogens predicts: Under shared_conditions and the time-indexed effect definition in competition_interpretation, first identify an organism and an anatomically constrained viable reservoir, with an organism/assay-specific upper bound on low or nonproductive baseline output and a predeclared site/window. No organism, site or threshold is supplied. Demonstrate linkage of genuinely new productive output to that same reservoir rather than another site or new exposure. A specified rebuilding-associated host change must precede the rise, followed by local injury and delayed loss despite genuine early adaptation. Repeat this ordering across natural tolerated episodes and quantify output burden, recurrence, injury and functional magnitude. Organism-appropriate orthogonal assays must distinguish productive output from persistent nucleic acid, static antigen, abortive expression, noninfectious particles, redistribution and fragments released after damage. The ordinary alternative at the same initial states, tolerated demands and times permits sterile immune injury and fragments, already active or independently fluctuating infection, reinfection, or stress/immune-containment changes without rebuilding as a gate. Separate two causal questions. For the total effect of suppressing demonstrated new productive output, define t0 before suppression; compare pre-t0 reservoir/output history, host rebuilding, synthesis/fidelity, inflammation, metabolism, mechanics, catalytic state, viable mass, force and work history, with comparable independently imposed demand where feasible. Only after an observed transition, a state-preserving contained preparation and a sufficiently selective pathogen-specific perturbation exist does reduced output followed by reduced new injury support infection-dependent protection. Direct drug effects on inflammation, metabolism, rebuilding, fidelity, mechanics, chemistry, viability or contraction that bypass output reduction must be assessed and separated where possible; otherwise a rescue is only a total intervention effect. In contrast, downstream changes caused by lower infection in those same host variables, including subsequent achieved work, viable mass and force, are intended mediators or outcomes and are included in the total infection effect. Reduced downstream inflammation or catalysis is compatible with infection causality, not a specificity failure. Do not require post-suppression host fidelity, mechanics, chemistry or force to remain equal. Controlled direct-effect contrasts fixing specified host mediators are additional questions only if independently feasible with overlap. Record any changed imposed activity exposure separately. For the distinctive rebuilding gate, output suppression alone is insufficient. A preparation must retain the same viable reservoir-host transition. Identify the proposed rebuilding change and, only if possible, selectively vary it before productive output while comparing pre-gate stress, injury, immune containment, nutrient availability and baseline host/organism capacity. Determine whether gate-associated changes act through an explicitly specified permissiveness pathway or are independently caused alternatives; measure their trajectories without automatically matching away any proposed gate mediator. A manipulation merely reducing general replication capacity or host survival does not identify a rebuilding gate. If rebuilding cannot be separated from its covarying alternatives, keep the gate unverified even if infection-dependent injury is supported. Conditional restoration must reproduce the same host-state transition and organism; fragments or an unrelated imposed infection cannot validate it. Existing damage need not reverse immediately. A verified reduction in output without less new injury over an adequately sensitive causal window constrains ongoing dependence locally, not all historical infection effects. Negative samples constrain the named organism, site, sensitivity and window, not every reservoir and not a rival. Susceptibility, safe duration, relapse after withdrawal, host defense and activity-preserving net benefit remain unknown.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.